Venous thromboembolism: A problem in the Indian/Asian population?

Indian Journal of Urology

Volumn 25, Issue 1, 2009, Pages 11-16

  Agarwal, Sunil ^a   Lee, Arvind ^b   Raju, Ravish ^a   Stephen, Edwin ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Thromboembolism; Urology; Venous

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; D DIMER; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ALGORITHM; ANTICOAGULANT THERAPY; ASIAN; BLEEDING; CANCER PATIENT; CAUSE OF DEATH; CLINICAL PRACTICE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; INDIA; INDIAN; LABORATORY TEST; LEG COMPRESSION; LUNG ANGIOGRAPHY; LUNG EMBOLISM; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PATIENT MONITORING; PHLEBOGRAPHY; POPULATION RISK; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPINAL CORD INJURY; STROKE; SURGICAL PATIENT; THROMBOSIS PREVENTION; TREATMENT OUTCOME; ULTRASOUND; UROLOGIC SURGERY; VENOUS THROMBOEMBOLISM;

EID: 60849126421     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.45531     Document Type: Review

References (32)

1. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism: A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996;93:2212-45.
2. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest 2001;119:132S-75S.
3. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 1991;151:933-8.
4. Bagaria V, Modi N, Panghate A, Vaidya S. Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: Results of a prospective study. Postgrad Med J 2006;82:136-9.
5. Agarwala S, Bhagwat AS, Modhe J. Deep vein thrombosis in Indian patients undergoing major lower limb surgery. Indian J Surg 2003;65:159-62.
6. Lee LH, Gu KQ, Heng D. Deep vein thrombosis is not rare in Asia - the Singapore General Hospital experience. Ann Acad Med Singapore 2002;31:761-4.
7. Dhillon KS, Askander A, Doraismay S. Postoperative deep-vein thrombosis in Asian patients is not a rarity: A prospective study of 88 patients with no prophylaxis. J Bone Joint Surg Br 1996;78:427-30.
8. Ko PS, Chan WF, Siu TH, Khoo J, Wu WC, Lam JJ. Deep venous thrombosis after total hip or knee arthroplasty in a "low-risk" Chinese population. J Arthroplasty 2003;18:174-9.
9. Leizorovicz A, Turpie AG, Cohen AT, Wong L, Yoos MC, Dans A, et al. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis: The SMART study. J Thromb Haemost 2005;3:28-34.
10. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 2000;160:809-15.
11. Hull RD, Raskob GE, Hirsh J. Prophylaxis of venous thromboembolism: An overview. Chest 1986;89:374S-83S.
12. Hull R, Delmore T, Genton E, Hirsh J, Gent M, Sackett D, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855-8.
13. Huisman MV, Büller HR, ten Cate JW, van Royen EA, Vreeken J, Kersten MJ, et al. Unexpected high prevalence of silent pulmonary embolism in patients with deepvenous thrombosis. Chest 1989;95:498-502.
14. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:259-70.
15. Criado E, Burnham CB. Predictive value of clinical criteria for the diagnosis of deep vein thrombosis. Surgery 1997;122:578-83.
16. Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997;350:1795-8.
17. Wolf B, Nichols DM, Duncan JL. Safety of a single duplex scan to exclude deep venous thrombosis. Br J Surg 2000;87:1525-8.
18. Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliott CG, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;326:975-82.
19. Prandoni P, Lensing AW, Büller HR, Carta M, Cogo A, Vigo M, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992;339:441-5.
20. Lopaciuk S, Meissner AJ, Filipecki S, Zawilska K, Sowier J, Ciesielski L, et al. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: A Polish multicenter trial. Thromb Haemost 1992;68:14-8.
21. Simonneau G, Charbonnier B, Decousus H, Planchon B, Ninet J, Sie P, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenousunfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 1993;153:1541-6.
22. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: A meta-analysis of randomized, controlled trials. Ann Intern Med 1999;130:800-9.
23. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:176S-193S.
24. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318:1162-73.
25. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, et al. Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003;28:172-97.
26. Nurmohamed MT, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandenbroucke JP, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedicsurgery: A meta-analysis. Lancet 1992;340:152-6.
27. Palmer AJ, Koppenhagen K, Kirchhof B, Weber U, Bergemann R. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: A meta-analysis of randomised clinical trials. Haemostasis 1997;27:75-84.
28. Kibel AS, Loughlin KR. Pathogenesis and prophylaxis of postoperative thromboembolic disease in urological pelvic surgery. J Urol 1995;153:1763-74.
29. Scarpa RM, Carrieri G, Gussoni G, Tubaro A, Conti G, Pagliarulo V, et al. Clinically overt venous thromboembolism after urologic cancer surgery: Results from the @RISTOS Study. Eur Urol 2007;51:130-5; discussion 136.
30. Galvin DJ, Mulvin D, Quinlan DM. Thromboprophylaxis for radical prostatectomy: A comparative analysis of present practice between the USA, the UK, and Ireland. Prostate 2004;60:338-42.
31. Donat R, Mancey-Jones B. Incidence of thromboembolism after transurethral resection of the prostate (TURP): A study on TED stocking prophylaxis and literature review. Scand J Urol Nephrol 2002;36:119-23.
32. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW; Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):381S-453S.